Pathophysiological Analysis of Drug-induced Allergic Diseases Including Perioperative Anaphylaxis and Desensitization Allergy

Pathophysiological Analysis of Drug-induced Allergic Diseases Including Perioperative Anaphylaxis and Desensitization Allergy - Pathophysiological Analysis of Drug-induced Allergic Diseases Including Perioperative Anaphylaxis and Desensitization Allergy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000057727

Enrollment

Registered

2025-04-28

Start date

2024-06-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaphylaxis, drug-induced allergy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who have agreed to participate in this study will be selected from those who meet the eligibility criteria.

Exclusion criteria

Exclusion criteria: 1) Patients who are unable to be informed of their diagnosis. 2) Patients whom the physician deems unsuitable for the study.

Design outcomes

Primary

Measure	Time frame
We will investigate the relationships between patients' clinical symptoms, medical information, results of BAT, DLST, and skin allergy tests, and molecular findings such as mRNA expression in blood cells and skin-resident cells.	—

Secondary

Measure	Time frame
We will evaluate the diagnostic specificity of various diagnostic criteria for anaphylaxis, including the WAO criteria, the Brighton criteria, and composite scores.	—

Countries

Japan

Contacts

Public ContactUtako Karigane

Keio University School of Medicine Department of Dermatology

utakookata.derma@keio.jp03-5363-3823

Outcome results